-
All Events
2025 ACOG Annual Clinical and Scientific MeetingACOG 2024 Armed Forces District Annual MeetingACOG 2024 Districts I, V & VI Annual District Meeting2024 ACOG Annual Clinical and Scientific Meeting2023 Districts I & V Annual District MeetingACOG District VI2023 Armed Forces District Annual Meeting2023 ACOG Annual Clinical and Scientific MeetingDistrict I 2022ACOG Armed Forces District: 2022District XI 20222022 ACOG Annual Clinical and Scientific Meeting2021 District XI Virtual Meeting2021 Armed Forces District (AFD) Virtual Meeting2021 District IV Virtual Annual MeetingACOG 2020 Virtual Conference -
All Content TypesAbstractePosterLearning modulePPT SharedWebcast
-
Sort ByRelevanceMost RecentAlphabetical OrderHighest ContributorsOldest
Protected by US Patents
Abstract
Discussion Forum (0)
Introduction: The utilization of long acting reversible contraception has remained low. Pain and anxiety associated with intrauterine device (IUD) placement are barriers. The purpose of this study was to investigate the effects of cervical lidocaine injections and oral diazepam on pain and anxiety during office IUD insertion.
Methods: Following Institutional Review Board approval, subjects desiring IUD placement were randomized to diazepam 5mg orally with cervical injections of 2.5ml of 2% lidocaine or placebo pill with saline injections. Both groups received 800mg oral Ibuprofen. Providers and subjects were blinded to their assigned group. Primary outcome was pain on a visual analog scale at various steps of IUD insertion. Power analysis set enrollment at 58, which is ongoing.
Results: At interim analysis, a total of 41 women have been enrolled. Of these, 39 (20 in the study arm, 19 in the placebo arm) underwent IUD insertion. Median anxiety was significantly decreased when placing the speculum in the study arm compared to placebo (5.5mm vs. 31mm; p=0.004) respectively. Additionally, subjects in the intervention group reported lower pain scores during insertion of the IUD (24mm vs. 71mm, p=0.030).
Conclusion/Implications: At interim analysis, oral diazepam and cervical lidocaine injections compared to placebo show clinically significant decreases in anxiety and pain during IUD placement. If these early results are confirmed, the use of cervical lidocaine injections and oral diazepam may provide additional tools to help increase utilization of IUDs by decreasing pain and anxiety associated with insertion.
Methods: Following Institutional Review Board approval, subjects desiring IUD placement were randomized to diazepam 5mg orally with cervical injections of 2.5ml of 2% lidocaine or placebo pill with saline injections. Both groups received 800mg oral Ibuprofen. Providers and subjects were blinded to their assigned group. Primary outcome was pain on a visual analog scale at various steps of IUD insertion. Power analysis set enrollment at 58, which is ongoing.
Results: At interim analysis, a total of 41 women have been enrolled. Of these, 39 (20 in the study arm, 19 in the placebo arm) underwent IUD insertion. Median anxiety was significantly decreased when placing the speculum in the study arm compared to placebo (5.5mm vs. 31mm; p=0.004) respectively. Additionally, subjects in the intervention group reported lower pain scores during insertion of the IUD (24mm vs. 71mm, p=0.030).
Conclusion/Implications: At interim analysis, oral diazepam and cervical lidocaine injections compared to placebo show clinically significant decreases in anxiety and pain during IUD placement. If these early results are confirmed, the use of cervical lidocaine injections and oral diazepam may provide additional tools to help increase utilization of IUDs by decreasing pain and anxiety associated with insertion.
Introduction: The utilization of long acting reversible contraception has remained low. Pain and anxiety associated with intrauterine device (IUD) placement are barriers. The purpose of this study was to investigate the effects of cervical lidocaine injections and oral diazepam on pain and anxiety during office IUD insertion.
Methods: Following Institutional Review Board approval, subjects desiring IUD placement were randomized to diazepam 5mg orally with cervical injections of 2.5ml of 2% lidocaine or placebo pill with saline injections. Both groups received 800mg oral Ibuprofen. Providers and subjects were blinded to their assigned group. Primary outcome was pain on a visual analog scale at various steps of IUD insertion. Power analysis set enrollment at 58, which is ongoing.
Results: At interim analysis, a total of 41 women have been enrolled. Of these, 39 (20 in the study arm, 19 in the placebo arm) underwent IUD insertion. Median anxiety was significantly decreased when placing the speculum in the study arm compared to placebo (5.5mm vs. 31mm; p=0.004) respectively. Additionally, subjects in the intervention group reported lower pain scores during insertion of the IUD (24mm vs. 71mm, p=0.030).
Conclusion/Implications: At interim analysis, oral diazepam and cervical lidocaine injections compared to placebo show clinically significant decreases in anxiety and pain during IUD placement. If these early results are confirmed, the use of cervical lidocaine injections and oral diazepam may provide additional tools to help increase utilization of IUDs by decreasing pain and anxiety associated with insertion.
Methods: Following Institutional Review Board approval, subjects desiring IUD placement were randomized to diazepam 5mg orally with cervical injections of 2.5ml of 2% lidocaine or placebo pill with saline injections. Both groups received 800mg oral Ibuprofen. Providers and subjects were blinded to their assigned group. Primary outcome was pain on a visual analog scale at various steps of IUD insertion. Power analysis set enrollment at 58, which is ongoing.
Results: At interim analysis, a total of 41 women have been enrolled. Of these, 39 (20 in the study arm, 19 in the placebo arm) underwent IUD insertion. Median anxiety was significantly decreased when placing the speculum in the study arm compared to placebo (5.5mm vs. 31mm; p=0.004) respectively. Additionally, subjects in the intervention group reported lower pain scores during insertion of the IUD (24mm vs. 71mm, p=0.030).
Conclusion/Implications: At interim analysis, oral diazepam and cervical lidocaine injections compared to placebo show clinically significant decreases in anxiety and pain during IUD placement. If these early results are confirmed, the use of cervical lidocaine injections and oral diazepam may provide additional tools to help increase utilization of IUDs by decreasing pain and anxiety associated with insertion.
Double-blinded, randomized, placebo-controlled trial of multimodal analgesia at intrauterine device insertion
Anna Zdroik
Affiliations:
Trihealth OBGYN PGY4
Trihealth OBGYN PGY4
Abstract
Discussion Forum (0)
Introduction: The utilization of long acting reversible contraception has remained low. Pain and anxiety associated with intrauterine device (IUD) placement are barriers. The purpose of this study was to investigate the effects of cervical lidocaine injections and oral diazepam on pain and anxiety during office IUD insertion.
Methods: Following Institutional Review Board approval, subjects desiring IUD placement were randomized to diazepam 5mg orally with cervical injections of 2.5ml of 2% lidocaine or placebo pill with saline injections. Both groups received 800mg oral Ibuprofen. Providers and subjects were blinded to their assigned group. Primary outcome was pain on a visual analog scale at various steps of IUD insertion. Power analysis set enrollment at 58, which is ongoing.
Results: At interim analysis, a total of 41 women have been enrolled. Of these, 39 (20 in the study arm, 19 in the placebo arm) underwent IUD insertion. Median anxiety was significantly decreased when placing the speculum in the study arm compared to placebo (5.5mm vs. 31mm; p=0.004) respectively. Additionally, subjects in the intervention group reported lower pain scores during insertion of the IUD (24mm vs. 71mm, p=0.030).
Conclusion/Implications: At interim analysis, oral diazepam and cervical lidocaine injections compared to placebo show clinically significant decreases in anxiety and pain during IUD placement. If these early results are confirmed, the use of cervical lidocaine injections and oral diazepam may provide additional tools to help increase utilization of IUDs by decreasing pain and anxiety associated with insertion.
Methods: Following Institutional Review Board approval, subjects desiring IUD placement were randomized to diazepam 5mg orally with cervical injections of 2.5ml of 2% lidocaine or placebo pill with saline injections. Both groups received 800mg oral Ibuprofen. Providers and subjects were blinded to their assigned group. Primary outcome was pain on a visual analog scale at various steps of IUD insertion. Power analysis set enrollment at 58, which is ongoing.
Results: At interim analysis, a total of 41 women have been enrolled. Of these, 39 (20 in the study arm, 19 in the placebo arm) underwent IUD insertion. Median anxiety was significantly decreased when placing the speculum in the study arm compared to placebo (5.5mm vs. 31mm; p=0.004) respectively. Additionally, subjects in the intervention group reported lower pain scores during insertion of the IUD (24mm vs. 71mm, p=0.030).
Conclusion/Implications: At interim analysis, oral diazepam and cervical lidocaine injections compared to placebo show clinically significant decreases in anxiety and pain during IUD placement. If these early results are confirmed, the use of cervical lidocaine injections and oral diazepam may provide additional tools to help increase utilization of IUDs by decreasing pain and anxiety associated with insertion.
Introduction: The utilization of long acting reversible contraception has remained low. Pain and anxiety associated with intrauterine device (IUD) placement are barriers. The purpose of this study was to investigate the effects of cervical lidocaine injections and oral diazepam on pain and anxiety during office IUD insertion.
Methods: Following Institutional Review Board approval, subjects desiring IUD placement were randomized to diazepam 5mg orally with cervical injections of 2.5ml of 2% lidocaine or placebo pill with saline injections. Both groups received 800mg oral Ibuprofen. Providers and subjects were blinded to their assigned group. Primary outcome was pain on a visual analog scale at various steps of IUD insertion. Power analysis set enrollment at 58, which is ongoing.
Results: At interim analysis, a total of 41 women have been enrolled. Of these, 39 (20 in the study arm, 19 in the placebo arm) underwent IUD insertion. Median anxiety was significantly decreased when placing the speculum in the study arm compared to placebo (5.5mm vs. 31mm; p=0.004) respectively. Additionally, subjects in the intervention group reported lower pain scores during insertion of the IUD (24mm vs. 71mm, p=0.030).
Conclusion/Implications: At interim analysis, oral diazepam and cervical lidocaine injections compared to placebo show clinically significant decreases in anxiety and pain during IUD placement. If these early results are confirmed, the use of cervical lidocaine injections and oral diazepam may provide additional tools to help increase utilization of IUDs by decreasing pain and anxiety associated with insertion.
Methods: Following Institutional Review Board approval, subjects desiring IUD placement were randomized to diazepam 5mg orally with cervical injections of 2.5ml of 2% lidocaine or placebo pill with saline injections. Both groups received 800mg oral Ibuprofen. Providers and subjects were blinded to their assigned group. Primary outcome was pain on a visual analog scale at various steps of IUD insertion. Power analysis set enrollment at 58, which is ongoing.
Results: At interim analysis, a total of 41 women have been enrolled. Of these, 39 (20 in the study arm, 19 in the placebo arm) underwent IUD insertion. Median anxiety was significantly decreased when placing the speculum in the study arm compared to placebo (5.5mm vs. 31mm; p=0.004) respectively. Additionally, subjects in the intervention group reported lower pain scores during insertion of the IUD (24mm vs. 71mm, p=0.030).
Conclusion/Implications: At interim analysis, oral diazepam and cervical lidocaine injections compared to placebo show clinically significant decreases in anxiety and pain during IUD placement. If these early results are confirmed, the use of cervical lidocaine injections and oral diazepam may provide additional tools to help increase utilization of IUDs by decreasing pain and anxiety associated with insertion.
{{ help_message }}
{{filter}}